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Abstract
Congenital heart defects remain a leading cause of infant mortality in the western world, despite 
decades of research focusing on cardiovascular development and disease,. With the recent 
emergence of several high-throughput technologies including RNA sequencing, chromatin 
immunoprecipitation-coupled sequencing, mass spectrometry-based proteomics analyses, and the 
numerous variations of these strategies, investigations into cardiac development have been 
transformed from candidate-based studies into whole-genome, -transcriptome, and -proteome 
undertakings. In this review, we discuss several reports that have emerged from our lab and others 
over the last five years that emphasize the versatility of large dataset-based investigations of 
cardiogenic transcription factors, from phenotypic validations and new gene implications to the 
identification of novel roles of well-studied transcriptional regulators.
Broadening the understanding of cardiac development and disease
A growing body of work has indicated an association between mutations in several 
transcription factors (TFs) and congenital heart disease (CHD) (Bruneau, 2013; Prendiville 
et al., 2014), highlighting the need to elucidate the transcriptional regulation of various 
aspects of cardiovascular development. High-throughput technologies have dramatically 
broadened the capacity in which to study regulators of gene networks (see Figure 1 for an 
overview of the main high-throughput technologies discussed here). High-throughput 
sequencing of a cell’s transcriptional profile (RNA-seq) allows for comparison of 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Trends Genet. Author manuscript; available in PMC 2018 February 27.
Published in final edited form as:
Trends Genet. 2016 November ; 32(11): 707–716. doi:10.1016/j.tig.2016.09.002.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
transcriptome-wide expression datasets between wild-type and loss- or gain-of-function 
conditions. Similarly, coupling high-throughput sequencing to chromatin 
immunoprecipitation (ChIP-seq) affords global views of DNA-binding proteins’ genomic 
occupancies. These strategies provide valuable insights into the targets and pathways 
controlled by transcriptional regulators. Additionally, mass spectrometry-based proteomics 
furthers understanding of the complex interactions among transcription factors, epigenetic 
modifiers, and the transcriptional machinery. Application of these strategies to investigations 
of cardiovascular biology provide a systems-level comprehension of transcriptional 
regulation not only of normal cardiac development, but of aberrant transcriptional programs 
that lead to both CHD and idiopathic heart disease.
Transcriptomic Analyses of Cardiac Development
Differential gene expression analysis, in which RNA-seq datasets of different biological 
states are compared to identify altered levels of gene products, has become the foundation of 
investigations into TF function. This approach was used to study the role of Mef2c, a key 
cardiogenic TF (Lin et al., 1997), in outflow tract (OFT) development (Barnes et al., 2016). 
The murine conditional loss-of-function model Myocyte Enhancer Factor 2C-conditional 
gene knockout (Mef2c-CKO) recapitulated OFT alignment defects seen in a human CHD 
patient harboring a mutation in Mef2c (Kodo et al., 2012). Differential RNA-seq gene 
expression analysis identified teratocarcinoma-derived growth factor 1 (Tdgf1) as a highly 
down-regulated transcript in Mef2c-CKO OFTs. An essential co-receptor for the Nodal 
subfamily of TGFβ ligands, Tdgf1 is also mutated in cases of human CHD (Ding et al., 
1998; Roessler et al., 2008; Shen and Schier, 2000; Wang et al., 2011). Therefore, the 
authors’ findings implied that Mef2c regulated OFT response to Nodal signaling during late 
cardiovascular development. Of future interest is the mechanistic role that Nodal 
responsiveness plays in properly aligning and connecting the OFT to the vasculature.
Similarly, differential gene expression analysis was used to investigate the cardiogenic 
effects of Forkhead Box C1 (Foxc1) haploinsufficiency (Lambers et al., 2016), which causes 
ventricular septal defects in Axenfeld-Rieger syndrome patients (Honkanen et al., 2003; 
Mears et al., 1998). Using an inducible overexpression system in differentiating murine 
embryonic stem cells (mESCs), the authors identified Foxc1-responsive signaling pathways 
in addition to genes that are critical to cardiomyocyte differentiation, structure, and function. 
This analysis complemented a candidate-based assay of Foxc1 depletion effects on 
established cardiogenic regulators, including T-box transcription factor 1 (Tbx1), the only 
previously known direct Foxc1 target (Yamagishi et al., 2003), as well as Mef2c, Isl1, and 
Nkx2.5. Together, these results indicated the importance of Foxc1 in regulating various 
aspects of cardiomyocyte development, from the exit of pluripotency to building a 
functionally mature myocardium.
Recently, the transcriptomic dynamics of the differentiation of mesoderm posterior 1 
(MESP1)-positive human embryonic stem cells (hESCs) into cardiomyocytes were 
comprehensively profiled (den Hartogh et al., 2016). In addition to categorizing the 
expression patterns of known cardiogenic TFs into a concise interaction network, their study 
provided new preliminary insights into the path from pluripotency to terminal myocardial 
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differentiation. The authors reported a host of potential new transcriptional regulators in 
various stages of cardiomyocyte development, and their work identified new cell-surface 
molecules as potential temporal markers of cardiovascular subpopulations during 
differentiation. Finally, the authors introduced a previously unrecognized role for 
extracellular matrix (ECM) dynamics in maintaining the appropriate microenvironments as 
the mesoderm and cardiac precursors develop further down the cardiac lineage. Overall, this 
RNA-seq based analysis provides the scientific community with a useful resource for 
profiling transcriptional changes during cardiomyocyte development and opens an array of 
new research avenues into the differentiation of cardiac cell fates.
Using ChIP-seq to Probe Transcription Factor Occupancy and Epigenetic 
Dynamics
In addition to revealing new transcriptional targets and genetic programs regulated by TFs, 
high-throughput sequencing approaches have elucidated genome-wide chromatin dynamics 
as a consequence of TF binding. One study conducted a systematic analysis of chromatin 
modification changes induced by alterations in Gata4 binding during cardiac development 
and disease (He et al., 2014). As a pioneer TF in the cardiac cell lineage, Gata4 establishes 
regions of open chromatin by recruiting histone modifiers such as the histone 
acetyltransferase (HAT) p300 to its target loci (Cirillo et al., 2002; Dai and Markham, 2001; 
He et al., 2011; Kuo et al., 1997). The authors correlated Gata4 occupancy with patterns of 
histone modifications in fetal and adult heart tissue, revealing a fundamental spatial shift in 
Gata4 binding on its active targets. During development, Gata4 localized to active enhancers 
at significant distances from transcriptional start sites (TSSs; Figure 2A), whereas Gata4 
binding occurred at TSS-proximal sites in adults (Figure 2B). This shift accompanied a 
change in the enrichment of potential cofactor binding motifs between the fetal and adult 
heart, suggesting that cofactor availability governs Gata4 binding site choices. Finally, the 
authors investigated the prevailing model of fetal gene reactivation as the mechanism of 
stress-induced cardiac hypertrophy (Oka et al., 2007) and extended their promoter/enhancer 
occupancy analysis to a murine pressure-overload model of hypertrophy. Indeed, Gata4 
reestablished occupancy at a subset of its fetal binding sites, supporting the contribution of 
developmental program reactivation to cardiac hypertrophy. However, a large portion of 
hypertrophy-associated Gata4 binding sites were never bound in either the fetal or healthy 
adult heart (Figure 2C), suggesting a greater importance of novel Gata4 binding events in the 
development of hypertrophic complications.
In another insightful investigation into Gata4 function, the tissue-specific activities of Gata4-
responsive enhancers in the atrioventricular canal (AVC) and the chamber myocardium were 
analyzed (Stefanovic et al., 2014). In this study, the authors combined transgenic reporter 
activity analysis with whole-genome assessments of TF chromatin binding and histone 
modification patterns. This strategy enabled the identification of regulatory elements that 
behave as switches, modulating Gata4-mediated transcription based on the expression of 
tissue-specific cofactors. In the AVC, Gata4 occupancy was correlated with that of the HAT 
p300, as well as with the enrichment of the active-enhancer histone H3 lysine 27 acetylation 
(H3K27ac) mark on enhancers of several genes involved in AVC identity (e.g. Tbx2, Tbx3;
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(Habets et al., 2002; Hoogaars et al., 2004) . In the chamber myocardium, these same 
regulatory elements lacked H3K27ac but the colocalization of Gata4 and histone 
deacetylases (HDACs) was observed. The opposite was apparent on Gata4-bound elements 
of genes that are important for chamber formation, such as Nppa and Hey2 (Houweling et 
al., 2005; Leimeister et al., 1999; Nakagawa et al., 1999). These sites were enriched for 
H3K27ac in the chamber myocardium but lacked the active-enhancer mark in the AVC. The 
authors built on this tissue-specific chromatin occupancy by integrating signaling pathway 
activity into the choice of transcriptional activation or repression. In both in vitro and in vivo 
experiments, they demonstrated that Bmp signaling, which is involved in AVC development 
and functionally interacts with both Gata4 and HATs (Dai and Markham, 2001; Kawamura 
et al., 2005; Ma et al., 2005; Moskowitz et al., 2011; Ross et al., 2006), synergized with 
Gata4 occupancy at the AVC enhancers to stimulate transcriptional activity. Conversely, in 
the chamber myocardium, inactivation of the AVC enhancers corresponded to active Notch 
signaling and occupancy of the Notch transcriptional effector Hey2. Intriguingly, the in vitro 
activation of a Gata4-responsive enhancer construct by Gata4 and Bmp2 was completely 
suppressed by Hey1/2 activity, highlighting the importance of the interplay of signaling 
pathways in determining regulatory element states.
Collectively, these mechanistic studies of Gata4 function highlight the versatility of high-
throughput sequencing approaches for gaining new functional insights into well-studied 
developmental TFs, as well as for elucidating the causal mechanisms of disease states.
Combining Transcriptome and Chromatin Dynamics of Cardiogenic 
Transcription Factors
A widely used strategy to probe the functions of transcriptional regulators combines whole-
transcriptome profiling with the high-throughput sequencing of TF-bound genomic regions. 
This workflow allows for genome-wide identification of directly activated and directly 
repressed TF targets. Applying this strategy to the Hippo-pathway transcriptional coactivator 
Yes-associated protein (YAP), the phosphoinositol-3-kinase catalytic subunit Pi3kcb was 
identified as a downstream regulator of cardiomyocyte proliferation and survival (Lin et al., 
2015). YAP localized to an intron in the Pi3kcb locus through an interaction with the DNA-
binding TF TEA Domain Family Member 1 (TEAD1). Furthermore, altering the expression 
of YAP both in vitro and in vivo positively correlated with changes in Pi3kcb expression. 
Mechanistically, the authors showed that Pi3kcb mediated the regulation of AKT signaling 
by YAP in order to positively regulate cardiomyocyte proliferation in both healthy mice and 
murine models of myocardial infarction. In summary, through a combination of high-
throughput sequencing technologies, an enzymatic signaling pathway was identified as a 
new key regulator of cardiomyocyte growth in development and disease.
Using a similar strategy, a functional link between Hedgehog signaling and Tbx5-mediated 
transcriptional regulation during second heart field (SHF) specification was revealed 
(Hoffmann et al., 2014), confirming their previously identified genetic interaction (Xie et al., 
2012). The authors overlaid SHF-specific ChIP-seq data for Glioblastoma 3 (Gli3), a major 
transcriptional effector of the Hedgehog pathway, with a differential gene expression 
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analysis of Sonic Hedgehog (Shh)-deficient SHF tissue. This approach led to the discovery 
that Foxf1a and Foxf2 are direct transcriptional targets of Hedgehog signaling in the 
posterior SHF. A genetic interaction between the two Forkhead box TFs confirmed their 
requirement for atrial septation, as double heterozygous mice phenocopied a loss of Shh 
signaling in the SHF. The authors then confirmed that Tbx5 and Gli3 co-occupied the same 
regulatory region of the Foxf1a locus, and demonstrated synergistic activity of Tbx5 and 
Gli3 on the genomic element in transient transcriptional assays. Altogether, this study 
utilized a combination of large dataset analysis to define an SHF-specific transcriptional 
regulatory network responsible for atrial septation. By identifying Foxf1a as an integrator of 
Hedgehog and Tbx5-mediated transcriptional regulation, the authors provided a mechanistic 
basis for the observed genetic interaction of the Hedgehog pathway and Tbx5 function. They 
likewise identified Foxf1a and Foxf2 as new players in the development of the atrial septum 
and as novel candidate genes for atrial septal defect (ASD)-based CHDs.
A combination of RNA-seq and ChIP-seq was also used to investigate the role of Sox9 in the 
development of the cardiac cushion mesenchyme, which gives rise to the valves of the heart 
(Garside et al., 2015). Sox9, a TF that is essential for proper murine valve formation and is 
mutated in human conditions that affect heart development, is expressed in numerous 
proliferating embryonic tissue types (Akiyama et al., 2002; Lincoln et al., 2007; Montero et 
al., 2002; Rockich et al., 2013; Trowe et al., 2010; Wagner et al., 1994). A comparison of 
genomic occupancy in cushions versus limb buds that was overlaid with a differential gene 
expression analysis identified both common and tissue-specific Sox9 functions. Although 
Sox9 localized to numerous cell-cycle regulator genes in both tissues, reinforcing its general 
role in proliferation, the authors found that Sox9 also directly regulated a host of well-
established valve-associated TFs, including Twist, Hand2, and Mecom/Evi1, as well as ECM 
components that are critical for valve formation. Furthermore, a significant portion of direct 
targets was upregulated upon loss of Sox9 function, indicating the dual mechanistic roles of 
Sox9 as both a transcriptional repressor and activator. In summary, this study utilized a 
combination of large dataset approaches to the understanding of Sox9 function in 
valvulogenesis as well as to extend the roles of this critical TF to tissue-specific cell fate 
decisions.
Using a combination of a genomic binding analysis and whole transcriptome profiling via 
microarray, mechanistic insights into cardiac arrhythmia-associated non-coding variants 
were revealed (van den Boogaard et al., 2012). The authors began with a systematic ChIP-
seq-based assessment of in vivo chromatin binding for TFs involved in the development of 
the cardiac conduction system, including the transcriptional repressor Tbx3. This analysis 
identified loci shared between Tbx3 and its relative Tbx5. However, the associated genes, 
highly enriched for ion channels and gap junctions, were activated by Tbx5 in non-
conduction cardiomyocytes but were repressed by Tbx3 in the conduction system. These 
findings are in line with previous reports that Tbx3-mediated transcriptional repression is 
critical for the proper differentiation of the conduction system myocardium (Bakker et al., 
2008; Hoogaars et al., 2007; Horsthuis et al., 2009). The authors demonstrated that a single 
nucleotide polymorphism present in a conserved Tbx3/Tbx5-bound enhancer of Scn5a, a 
sodium channel that is essential for rapid cardiomyocyte depolarization (Papadatos et al., 
2002), reduced Tbx3/Tbx5 binding affinity and, consequently, altered Scn5a expression. The 
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authors hypothesized that this enhancer plays an important role in distinguishing myocardial 
subpopulations by preferentially binding distinct TFs in different tissues. Furthermore, in 
combination with other non-coding variants, perturbation of this conserved regulatory 
sequence could significantly affect the proper expression of functional proteins that 
participate in cardiac conduction. Hence, these results offer insights into a mechanistic link 
between a disease phenotype and an associated genomic non-coding variant.
In addition to using large dataset platforms as initial screens to identify novel cardiogenic 
factors, technologies including RNA-seq and ChIP-seq have been applied directly to the 
molecular mechanisms of transcriptional regulation in cardiac development. ChIP-seq 
variations have been used to probe the interactions between the components of the well-
studied Nkx2.5-Tbx5-Gata4 triumvirate of cardiogenic TFs (Luna-Zurita et al., 2016) 
(Figure 3). The investigation began with the transcriptomic profiling of Nkx2.5 and Tbx5 
single- or double-knockout mESCs that differentiated along the cardiac lineage. 
Consequently, the analysis revealed an unexpectedly complex and dynamic relationship 
among genes regulated by each TF, implying a complicated temporal pattern of genomic co-
occupancy. Extending their analysis to include Gata4, the authors performed a 
comprehensive ChIP-exo-based survey of genomic binding for all three TFs during 
cardiomyocyte differentiation and found that their genomic occupancy results reflected the 
findings of their transcriptomic profiling. The relationships between binding positions 
proved to be temporally complex and dynamic, with examples of different occupancy 
combinations running the spectrum between all and none. Intriguingly, the loss of a single 
factor significantly altered the binding patterns of the others beyond the expected 
concomitant loss at co-bound loci (Figure 3B). Specifically, the absence of one factor often 
led to a strengthening of the binding of the other factors at ectopic sites, i.e. sites not 
normally bound in a wild-type situation (Figure 3A). This finding has surprising 
implications for the etiologies of CHDs caused by TF mutations, as disease phenotypes may 
not be the lone direct consequences of TF loss- or gain-of-function. Physiological 
complications might arise partially due to ectopically activated or repressed genetic 
programs as the binding partners of the mutated TFs are redistributed throughout the 
genome. Consequently, this study will likely have significant future impacts on the clinical 
views of CHD mechanisms and treatments.
Proteomics Analysis of Transcription Factor Coregulators
In addition to identifying downstream target genes for a given TF, significant progress has 
been made in elucidating the molecular mechanisms of gene regulation during cardiac 
development. Mass spectrometry has been used to identify the TF co-regulators involved in 
both cardiac chamber formation and epicardial maturation. For example, immunoisolation of 
Tcf21-containing transcriptional complexes revealed the transcriptional repression 
capabilities of this crucial epicardium-associated TF (Tandon et al., 2013). The results of this 
mechanistic investigation were substantiated by a differential RNA-seq gene expression 
analysis, which identified a host of proepicardium-expressed genes whose expression 
inappropriately persisted following the loss of Tcf21 function. Furthermore, the perdurance 
of these genes in the epicardial lineage coincided with the retention of proepicardium-like 
cellular phenotypes including persistent migratory behavior and failure to undergo a proper 
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mesenchymal-to-epithelial transition. Overall, this work identified transcriptional repression 
as a key role of Tcf21 during the transition of the proepicardial organ to a mature 
epicardium.
The transcriptional mechanisms employed by Tbx20, a T-box TF expressed throughout 
cardiac development in species ranging from flies to humans (Ahn et al., 2000; Brown et al., 
2003; Griffin et al., 2000; Iio et al., 2001; Meins et al., 2000), were studied using a similar 
approach (Kaltenbrun et al., 2013). The results of the proteomics analysis revealed that the 
Nucleosome Remodeling and Deacetylase (NuRD) complex, a chromatin-modifying 
transcriptional repression complex, is physically associated with Tbx20. The recruitment of 
NuRD activity to Tbx20 transcriptional targets is mediated by the interaction of Groucho/ 
transducin-like Enhancer of split (TLE) corepressors and an evolutionarily conserved 
Engrailed Homology 1 (Eh1) domain (Chen et al., 1999) in Tbx20, exemplifying a 
combinatorial specificity in the selection of regulatory mechanisms by DNA-binding TFs. 
After in vivo confirmation of the interaction of Tbx20 and TLE3 in murine embryonic 
hearts, the authors demonstrated the functional relevance of the Tbx20-TLE interaction via 
RNA-seq-based differential gene expression analysis. A mutation in the Eh1 domain 
diminished Tbx20 overexpression phenotypes in Xenopus embryos, concomitant with an 
upregulation of biologically relevant genes that are repressed by wild-type Tbx20. 
Interestingly, several of these genes play roles in cardiomyocyte differentiation. Given its 
persistent expression throughout early cardiac development, these findings suggest that 
Tbx20 might serve as a transcriptional switch, repressing cardiac genes until temporally 
regulated transcriptional coactivators displace Tbx20-associated corepressors during 
subsequent stages of differentiation.
Multiple-Platform Approaches to Studying Transcriptional Control of 
Cardiac Development
Combining the three major aspects of TF function, transcriptome dynamics, genome 
occupancy, and the cofactor interactome offers a powerful strategy for in-depth 
investigations into transcriptional regulation. A combination of differential gene expression 
analysis, ChIP-seq studies, and proteomics was used to provide intriguing insights into the 
function of Isl1 during the differentiation of cardiac progenitors (Wang et al., 2016). Using 
an ESC differentiation model to generate the cardiac progenitors, the authors identified 
direct transcriptional targets of Isl1. The onset of Isl1 occupancy correlated strongly with a 
switch from inactive- to active-enhancer epigenetic modifications, suggesting Isl1 recruits 
chromatin-modifying enzymes to stimulate target gene transcription. The knockdown of Isl1 
led to a loss of cardiomyocyte terminal differentiation, a marked reduction in Isl1 target gene 
expression, and the maintenance of inactive-enhancer chromatin marks. The authors 
identified Isl1 transcriptional coregulators via a proteomics screen and focused on JMJD3, a 
histone demethylase previously implicated in mesoderm specification and cardiac lineage 
differentiation (Ohtani et al., 2013). Partial depletion of JMJD3 impaired ESC 
cardiomyocyte differentiation, the expression of Isl1 transcriptional targets, and the 
clearance of the H3K27me3 repressive mark from Isl1-bound enhancers. Re-ChIP 
experiments indicated that Isl1 and JMJD3 co-occupied the same enhancer elements of 
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Mef2c and MyoD, two critical regulators of cardiomyocyte differentiation previously 
identified as Isl1 transcriptional targets (Dodou et al., 2004; Kwon et al., 2009; Takeuchi et 
al., 2005). Finally, the authors demonstrated that Isl1 knockdown prevented JMJD3 
occupancy at representative Isl1 target enhancers. Overall, these results greatly expand the 
current understanding of the molecular mechanisms by which an already well-studied TF 
regulates aspects of cardiac development.
The molecular mechanisms employed by the widely-studied cardiogenic T-box TF Tbx5 
were investigated in a comprehensive analysis utilizing multiple large dataset platforms 
(Waldron et al., 2016). Following a proteomics analysis of Tbx5 transcriptional coregulators, 
the authors discovered and biochemically verified a physical interaction between Tbx5 and 
the NuRD transcriptional repression complex. This physical interaction was functionally 
validated in vivo via a genetic interaction between Tbx5 and the NuRD component Mta1, 
with compound heterozygous mice displaying synergistic, severe cardiac abnormalities 
including atrioventricular septal defects. The authors biochemically mapped the NuRD-
interaction domain (NID) to a previously uncharacterized region of Tbx5 and identified 
human CHD patient mutations that fall in this region (Heinritz et al., 2005). After 
identifying the direct targets of Tbx5-mediated transcriptional repression via overlaying 
differential gene expression analysis with previously reported ChIP-seq data (He et al., 
2011), the authors demonstrated that the human CHD mutations in the Tbx5 NID not only 
disrupted the biochemical interaction but impaired the ability of Tbx5 to properly repress a 
subset of its targets (Figure 4). Finally, the authors undertook a phylogenetic analysis to 
highlight the strict evolutionary conservation of the Tbx5 NID sequence. In doing so, they 
revealed a potential causal relationship between the Tbx5-NuRD interaction and the 
evolution of atrial septation. Although the NID amino acid sequence is strictly conserved 
among vertebrates with septated hearts, those with unseptated hearts (e.g. zebrafish) bear 
NID substitutions that are identical to human CHD mutations. In addition to establishing 
Tbx5 as a repressor of gene programs incongruent with cardiomyocyte development, this 
work reveals the etiology of certain cases of human CHD and proposes a molecular 
mechanism for the evolution of cardiac chamber septation, namely the concurrent evolution 
of the interaction between Tbx5 and the NuRD repression complex.
Concluding Remarks
The establishment of genome, transcriptome, and proteome-wide analytical technologies has 
revolutionized molecular investigations into a wide array of biological questions. Research 
into CHD, a leading cause of infant mortality in the developed world, has already benefited 
tremendously in a short time from these large dataset strategies. As the technologies are 
standardized and optimized, costs are reduced, and large dataset platforms become more 
accessible to a greater number of researchers, insights into cardiovascular development and 
disease states will increase by orders of magnitude. Exciting future research prospects will 
move beyond investigations of a single or limited number of TFs and explore the roles of 
higher-order chromatin structures in cardiovascular biology. Pioneering work has already 
implicated chromatin looping and domain architecture in lineage specification, cardiac 
development, and disease, using chromatin conformation capture (3C) technologies coupled 
with high-throughput sequencing analysis (Aguirre et al., 2015; Caputo et al., 2015; Dowen 
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et al., 2014; Korostowski et al., 2011; Sergeeva et al., 2016). More widespread use of these 
strategies, in conjunction with large-scale proteomics analysis, could provide a wealth of 
information on spatiotemporal genome dynamics, as well as the compositions of protein 
complexes that mediate them. These efforts will, in turn, vastly improve our understanding 
of the factors and mechanisms at play during both normal cardiac development and 
cardiovascular disease states, including CHD.
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Outstanding Questions Box
How does combinatorial transcription factor binding regulate higher-order chromatin 
structure?
How does higher-order chromatin architecture govern proper cardiovascular 
development?
To what extent does ectopic transcription factor binding contribute to phenotypes of 
congenital and idiopathic heart disease?
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Trends Box
Large dataset platforms allow for systems-based investigations into transcription factor 
function during cardiovascular development.
Combining large dataset approaches provides comprehensive views of transcription 
factor function, revealing many transcriptional regulators to be both activators and 
repressors.
Transcription factor binding to both regulatory sequences and co-regulators is heavily 
context-dependent, relying on genomic element orientation and spacing, development-
dictated co-expression, and chromatin landscapes.
Upon mutation of cardiogenic transcription factors, redistribution of their co-regulators to 
ectopic genomic binding sites may contribute significantly to disease etiologies.
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Figure 1. An overview of large-dataset experimental approaches
RNA-seq, ChIP-seq, and proteomic analyses follow similar workflows. Briefly, starting 
material to be analyzed is isolated from cells or tissue. Enrichment steps, such as affinity 
purifications, can be employed to narrow the population of input material analyzed. 
Molecules of interest are then fragmented, either mechanically or enzymatically, to permit 
massively parallel sequence analysis. Resulting sequence data is compared to a reference 
database (either a transcriptome, a genome, or a peptide sequence collection) to attain 
identities of the molecules of interest.
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Figure 2. Dynamic GATA4 genomic occupancy governs epigenetic and physiological states of 
cardiac biology
A. In developing cardiomyocytes, GATA4 predominantly binds to distal enhancers of 
developmental genes and correlates with enrichment of H3K27 acetylation (green triangles 
on blue circles). Adult cardiac and non-cardiac genes, which are not expressed in developing 
cardiomyocytes, lack both GATA4 binding and H3K27 acetylation. B. Mature 
cardiomyocytes display a shift in both GATA4 occupancy and H3K27 acetylation from 
distal fetal enhancers to proximal adult enhancers. C. During disease states, GATA4 
reactivates a subset of its developmental targets, but also binds and activates non-cardiac 
genes, implying that these novel targets contribute significantly to disease phenotypes.
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Figure 3. Relative binding site orientations influence activities of heterotypic transcription factor 
complexes
A. The TBX5-GATA4-NKX2.5 complex binds to regulatory sequences in particular 
arrangements (e.g. proper combinations, spacing, head/tail orientations). Non-optimal 
binding sites are not occupied by the complex. B. Loss of complex members (e.g. GATA4-
null cardiomyocytes) can redistribute remaining members to ectopic sites in the genome, 
leading to inappropriate gene expression and potentially exacerbating loss-of-function 
phenotypes.
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Figure 4. TBX5 promotes cardiac septation via NuRD-mediated transcriptional repression
A. During cardiac development, TBX5 activates transcription of relevant downstream 
targets, including cardiomyocyte structural genes. At non-cardiac targets, TBX5 recruits the 
NuRD chromatin remodeling complex to inhibit lineage-inappropriate gene expression. 
Together, these functions allow for proper development and septation of the heart. B. 
Disruption of the TBX5-NuRD interaction (yellow star), either through disease mutations or 
evolutionary mechanisms, derepresses targets of TBX5-mediated repression, leading to 
congenital heart defects such as AVSDs.
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